Response-Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Response-adaptive randomization (RAR) can be challenging in clinical trials when primary endpoints are delayed. This study proposes using surrogate endpoints for RAR, ensuring patient benefit and valid statistical inference even with limited primary outcome data.
Area Of Science
- Clinical Trials
- Biostatistics
- Medical Research Methodology
Background
- Sequential subject recruitment is standard in clinical trials.
- Response-adaptive randomization (RAR) optimizes treatment allocation based on accumulating trial data.
- Limited primary endpoint data during recruitment hinders RAR application, especially in public health emergencies or chronic diseases.
Purpose Of The Study
- To propose a novel RAR procedure utilizing surrogate endpoints when primary endpoints are unavailable.
- To demonstrate the validity and patient benefit of RAR with surrogate endpoints.
- To explore the performance of this approach across different surrogate and primary endpoint types.
Main Methods
- Development of a response-adaptive randomization procedure relying solely on surrogate endpoints.
- Theoretical justification of statistical inference validity for the primary endpoint.
- Simulation studies to assess patient benefit and approach performance.
Main Results
- The proposed RAR procedure using surrogate endpoints is statistically valid.
- Simulations confirm the approach's viability and patient benefit.
- Effectiveness is demonstrated across various surrogate and primary endpoint combinations.
Conclusions
- RAR using surrogate endpoints offers a viable solution for clinical trials with delayed primary outcomes.
- This method enhances treatment allocation efficiency and patient benefit in challenging recruitment scenarios.
- Surrogate endpoints provide a practical alternative for adaptive trial designs when primary data is scarce.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.